Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mazdutide (IBI362) in Chinese Adolescents With Obesity or Overweight
NCT07255209Phase 3Recruiting
- Sponsor
- Innovent Biologics
- Start
- Dec 2025
- Primary completion
- Oct 2027
- Modality
- Hormonal Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of mazdutide in obesity, sponsored by Innovent Biologics. Started Dec 2025; status: recruiting.
02
Drugs
mazdutide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07255209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07255209.